The newspaper ABC has reported on a new project to be launched by IRB Barcelona researcher Roger Gomis thanks to a grant from the Fundación Fero y Mango. Focusing on luminal breast cancer, one of the most common subtypes, the project aims to decipher the “dialogue” between tumour cells and bone stem cells. This information can then be used to design therapeutic targets and to limit the capacity of these cells to metastasize. “This is a groundbreaking approach to tackle metastasis in this kind of cancer,” says Gomis.
Link to ABC
The newspapers El Mundo, La Vanguardia and Diari Ara, the TV station TV3 and the radio stationsCatalunya Ràdio andRAC1, among other media, have echoed on a study by the Biomedical Genommics lab, headed by Núria López, published in Nature Genetics. The study has for the first time determined the genetic mutations caused by various therapies used to treat cancer.
Scientists at IRB Barcelona determine the genetic alterations in the cells of cancer patients caused by the main cancer therapies.
This is an important step towards understanding the long-term side effects and optimizing treatments against cancer.
The results have been published in the journal Nature Genetics.
The funded project will address the development of metastasis in breast cancer.
The grant, which is specifically for research into breast cancer, has been given by the foundation, in collaboration with Mango.
Fero is a private foundation that promotes translational cancer research in Spain.
